Data analysis Data shown are mean standard error of the mean
Hydration and adverse-effect management Severe nausea, vomiting, diarrhea, constipation, or appetite suppression should not simply be accepted as proof that the medication is working. Tracking strength and function Notice what the body can do, not just what it weighs
Months 6 to 12 and beyond: maximum results and maintenance The STEP trials showed that semaglutide 2.4 mg produces an average of approximately 15% body weight loss by week 68, roughly 16 months
This is a common question, and the answer is unambiguous
Tirzepatide can help clarify which path makes the most sense for your goals
These are commonly used to treat diabetes and to manage weight/ obesity (especially in those with diabetes) 1 Most GLP-1 agonist side effects occur because these medications change how the digestive system and appetite-regulating pathways work